Early Complete Response Before the Second Cycle of Atezolizumab plus Bevacizumab After Locoregional Therapy in Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Lesions and Pulmonary Metastases
Kanzo · 01.07.2026 · 67 (4) · 345-354
DOI: 10.2957/kanzo.67.345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kanzo, erschienen am 01.07.2026. Verfasst von Hiroteru Kamimura und 17 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kamimura, H., Yamazaki, S., Natsui, H., Endo, S., Miida, S., Maruyama, H., Hanano, K., Yoshida, K., Fukushima, N., Morishita, K., Yakubo, S., Kumagai, M., Yoshida, T., Kimura, N., Abe, H., Yokoo, T., Sakamaki, A., & Terai, S. (2026). Early Complete Response Before the Second Cycle of Atezolizumab plus Bevacizumab After Locoregional Therapy in Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Lesions and Pulmonary Metastases. Kanzo, 67(4), 345-354. https://doi.org/10.2957/kanzo.67.345
Vancouver
Kamimura H, Yamazaki S, Natsui H, Endo S, Miida S, Maruyama H, et al. Early Complete Response Before the Second Cycle of Atezolizumab plus Bevacizumab After Locoregional Therapy in Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Lesions and Pulmonary Metastases. Kanzo. 2026;67(4):345-354. doi:10.2957/kanzo.67.345
BibTeX
@article{Kamimura2026,
author = {Kamimura, Hiroteru and Yamazaki, Shun and Natsui, Hiroki and Endo, Saori and Miida, Suguru and Maruyama, Hiroki and Hanano, Kaoru and Yoshida, Kotaro and Fukushima, Naoya and Morishita, Ken and Yakubo, Shunta and Kumagai, Masaru and Yoshida, Tomoaki and Kimura, Naruhiro and Abe, Hiroyuki and Yokoo, Takeshi and Sakamaki, Akira and Terai, Shuji},
title = {Early Complete Response Before the Second Cycle of Atezolizumab plus Bevacizumab After Locoregional Therapy in Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Lesions and Pulmonary Metastases},
journal = {Kanzo},
year = {2026},
volume = {67},
number = {4},
pages = {345--354},
doi = {10.2957/kanzo.67.345}
}
EUVIMED